Market Overview

Benzinga's Top Downgrades

Share:
Related PRXL
PAREXEL's Investment Day Leaves Citi Energized
PAREXEL's June 30 Investor Day Likely To Feature FY2017 Guidance
Is Medpace The Next Healthcare IPO Big Winner? (Seeking Alpha)
Related MT
Benzinga's Top Upgrades
Vetr Upgrades ArcelorMittal To 3 Stars

Analysts at Jefferies downgraded PAREXEL International (NASDAQ: PRXL) from “buy” to “hold.” PAREXEL's shares closed at $32.38 yesterday. PAREXEL's trailing-twelve-month ROA is 4.01%.

Analysts at Citigroup downgraded ArcelorMittal (NYSE: MT) from “buy” to “neutral.” ArcelorMittal's shares closed at $14.65 yesterday. ArcelorMittal's trailing-twelve-month profit margin is 0.69%.

Analysts at Goldman Sachs downgraded MeadWestvaco (NYSE: MWV) from “buy” to “neutral.” MeadWestvaco's shares closed at $31.20 yesterday. MeadWestvaco's PEG ratio is 2.16.

RBC Capital downgraded Endo Health Solutions (NASDAQ: ENDP) from “outperform” to “sector perform.” Endo Health's shares closed at $31.51 yesterday. Endo Health's trailing-twelve-month ROA is 5.13%.

Latest Ratings for PRXL

DateFirmActionFromTo
Aug 2016JefferiesMaintainsHold
Aug 2016Deutsche BankMaintainsHold
Aug 2016CitigroupMaintainsBuy

View More Analyst Ratings for PRXL
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (ENDP + MT)

View Comments and Join the Discussion!